Home Endo to pay $25M for nasal testosterone replacement therapy
 

Keywords :   


Endo to pay $25M for nasal testosterone replacement therapy

2014-11-25 00:20:24| Biotech - Topix.net

Endo International made a bigger push into the testosterone replacement therapy market Monday by agreeing to acquire the rights to Natesto for $25 million. Natesto is the only testosterone nasal gel approved by the Food and Drug Administration as a replacement therapy for adult males with hypogonadism - a condition where sex glands produce little or no sex hormones.

Tags: pay therapy replacement 25m

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.11Eastern North Pacific Tropical Weather Outlook
01.11Atlantic Tropical Weather Outlook
01.11How Japan's youngest CEO transformed Hello Kitty
31.10Unicharm to Expand in Africa
31.10Essity Named Diversity Leader by Financial Times
31.10Maxcess to Make FIFE Guiding Products in Mumbai
31.10Renee Starr Joins Hospeco
31.10RRD expands emissions reduction efforts
More »